Sort   by:  
 Page size 
UnknownCD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties.
Not available
S-EPMC8520003 | biostudies-literature
UnknownThe Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional Activity.
Not available
S-EPMC8773791 | biostudies-literature
UnknownPopulation-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities.
Not available
S-EPMC10670876 | biostudies-literature
UnknownReducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma.
Not available
S-EPMC10917787 | biostudies-literature
UnknownThe Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.
Not available
S-EPMC10486925 | biostudies-literature
UnknownWhole-body CD8<sup>+</sup> T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study.
Not available
S-EPMC12749833 | biostudies-literature
UnknownVISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responses.
Not available
S-EPMC10979580 | biostudies-literature
UnknownCD47-SIRPα blocking-based immunotherapy: Current and prospective therapeutic strategies.
Not available
S-EPMC9339239 | biostudies-literature
UnknownT-cell and antibody responses in immunocompromised patients with hematologic malignancies indicate strong potential of SARS-CoV-2 mRNA vaccines.
Not available
S-EPMC12580724 | biostudies-literature
UnknownImpact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey.
Not available
S-EPMC10112941 | biostudies-literature
Sort   by:  
 Page size